🚀 VC round data is live in beta, check it out!
Pro Medicus Valuation Multiples
Discover revenue and EBITDA valuation multiples for Pro Medicus and similar public comparables like Revvity, Guardant Health, bioMérieux, ICON plc and more.
Pro Medicus Overview
About Pro Medicus
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
Founded
1983
HQ
Employees
132
Website
Financials (LTM)
EV
$11B
Pro Medicus Financials
Pro Medicus reported last 12-month revenue of $182M and EBITDA of $161M.
In the same LTM period, Pro Medicus generated $182M in gross profit, $161M in EBITDA, and $111M in net income.
Revenue (LTM)
Pro Medicus P&L
In the most recent fiscal year, Pro Medicus reported revenue of $153M and EBITDA of $118M.
Pro Medicus expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $182M | XXX | $153M | XXX | XXX | XXX |
| Gross Profit | $182M | XXX | $153M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 100% | XXX | XXX | XXX |
| EBITDA | $161M | XXX | $118M | XXX | XXX | XXX |
| EBITDA Margin | 89% | XXX | 77% | XXX | XXX | XXX |
| EBIT Margin | 86% | XXX | 74% | XXX | XXX | XXX |
| Net Profit | $111M | XXX | $83M | XXX | XXX | XXX |
| Net Margin | 61% | XXX | 54% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Pro Medicus Stock Performance
Pro Medicus has current market cap of $11B, and enterprise value of $11B.
Market Cap Evolution
Pro Medicus' stock price is $106.48.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11B | $11B | 0.0% | XXX | XXX | XXX | $0.79 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPro Medicus Valuation Multiples
Pro Medicus trades at 60.2x EV/Revenue multiple, and 68.0x EV/EBITDA.
EV / Revenue (LTM)
Pro Medicus Financial Valuation Multiples
As of April 20, 2026, Pro Medicus has market cap of $11B and EV of $11B.
Equity research analysts estimate Pro Medicus' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pro Medicus has a P/E ratio of 99.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $11B | XXX | $11B | XXX | XXX | XXX |
| EV (current) | $11B | XXX | $11B | XXX | XXX | XXX |
| EV/Revenue | 60.2x | XXX | 71.8x | XXX | XXX | XXX |
| EV/EBITDA | 68.0x | XXX | 92.7x | XXX | XXX | XXX |
| EV/EBIT | 70.3x | XXX | 96.9x | XXX | XXX | XXX |
| EV/Gross Profit | 60.4x | XXX | 71.9x | XXX | XXX | XXX |
| P/E | 99.9x | XXX | 134.5x | XXX | XXX | XXX |
| EV/FCF | 121.9x | XXX | 147.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pro Medicus Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Pro Medicus Margins & Growth Rates
Pro Medicus' revenue in the last 12 month grew by 31%.
Pro Medicus' revenue per employee in the last FY averaged $1.2M, while opex per employee averaged $0.3M for the same period.
Pro Medicus' rule of 40 is 112% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pro Medicus' rule of X is 154% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Pro Medicus Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 31% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Margin | 89% | XXX | 77% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | 48% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 112% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 154% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 10% | XXX | 9% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 13% | XXX | 17% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Pro Medicus Public Comps
See public comps and valuation multiples for other Healthcare Software and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pro Medicus | XXX | XXX | XXX | XXX | XXX | XXX |
| Revvity | XXX | XXX | XXX | XXX | XXX | XXX |
| Guardant Health | XXX | XXX | XXX | XXX | XXX | XXX |
| bioMérieux | XXX | XXX | XXX | XXX | XXX | XXX |
| ICON plc | XXX | XXX | XXX | XXX | XXX | XXX |
| United Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pro Medicus M&A Activity
Pro Medicus acquired XXX companies to date.
Last acquisition by Pro Medicus was on XXXXXXXX, XXXXX. Pro Medicus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Pro Medicus
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPro Medicus Investment Activity
Pro Medicus invested in XXX companies to date.
Pro Medicus made its latest investment on XXXXXXXX, XXXXX. Pro Medicus invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Pro Medicus
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pro Medicus
| When was Pro Medicus founded? | Pro Medicus was founded in 1983. |
| Where is Pro Medicus headquartered? | Pro Medicus is headquartered in Australia. |
| How many employees does Pro Medicus have? | As of today, Pro Medicus has over 132 employees. |
| Who is the CEO of Pro Medicus? | Pro Medicus' CEO is Sam Aaron Hupert. |
| Is Pro Medicus publicly listed? | Yes, Pro Medicus is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Pro Medicus? | Pro Medicus trades under PME ticker. |
| When did Pro Medicus go public? | Pro Medicus went public in 2000. |
| Who are competitors of Pro Medicus? | Pro Medicus main competitors are Revvity, Guardant Health, bioMérieux, ICON plc. |
| What is the current market cap of Pro Medicus? | Pro Medicus' current market cap is $11B. |
| What is the current revenue of Pro Medicus? | Pro Medicus' last 12 months revenue is $182M. |
| What is the current revenue growth of Pro Medicus? | Pro Medicus revenue growth (NTM/LTM) is 31%. |
| What is the current EV/Revenue multiple of Pro Medicus? | Current revenue multiple of Pro Medicus is 60.2x. |
| Is Pro Medicus profitable? | Yes, Pro Medicus is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Pro Medicus? | Pro Medicus' last 12 months EBITDA is $161M. |
| What is Pro Medicus' EBITDA margin? | Pro Medicus' last 12 months EBITDA margin is 89%. |
| What is the current EV/EBITDA multiple of Pro Medicus? | Current EBITDA multiple of Pro Medicus is 68.0x. |
| What is the current FCF of Pro Medicus? | Pro Medicus' last 12 months FCF is $90M. |
| What is Pro Medicus' FCF margin? | Pro Medicus' last 12 months FCF margin is 49%. |
| What is the current EV/FCF multiple of Pro Medicus? | Current FCF multiple of Pro Medicus is 121.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.